Policies to increase the social value of science and the scientist satisfaction. An exploratory survey among Harvard bioscientists.

PubWeight™: 1.23‹?› | Rank: Top 10%

🔗 View Article (PMC 3999931)

Published in F1000Res on January 21, 2014

Authors

Andrea Ballabeni1, Andrea Boggio2, David Hemenway1

Author Affiliations

1: Department of Health Policy and Management, Harvard School of Public Health, Boston, MA, 02115, USA.
2: Department of History and Social Science, Bryant University, Smithfield, RI, 02917, USA.

Articles cited by this

A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet (2012) 50.94

Rescuing US biomedical research from its systemic flaws. Proc Natl Acad Sci U S A (2014) 14.78

A vision for the future of genomics research. Nature (2003) 14.06

Separate neural systems value immediate and delayed monetary rewards. Science (2004) 13.85

How to increase value and reduce waste when research priorities are set. Lancet (2014) 9.64

Normal Misbehavior: Scientists Talk about the Ethics of Research. J Empir Res Hum Res Ethics (2006) 3.25

Science's new social contract with society. Nature (1999) 2.72

Should we make a fuss? A case for social responsibility in science. Nat Biotechnol (2005) 2.40

Evaluation of the research norms of scientists and administrators responsible for academic research integrity. JAMA (1998) 2.30

Teaching scientists to be citizens. It is hard to become a good scientist. It is even harder to become a good citizen. EMBO Rep (2003) 1.82

Predicting scientists' participation in public life. Public Underst Sci (2012) 1.65

Scientist citizens. Science (2009) 1.61

Measuring the societal impact of research: research is less and less assessed on scientific impact alone--we should aim to quantify the increasingly important contributions of science to society. EMBO Rep (2012) 1.57

Geneticists' views on science policy formation and public outreach. Am J Med Genet A (2005) 1.53

Beyond scientific rigour: funding cancer research of public value. Health Policy (2007) 1.34

Estimating the NIH efficient frontier. PLoS One (2012) 1.20

Measuring consensus about scientific research norms. Sci Eng Ethics (2000) 1.12

Biomedical scientists' perceptions of ethical and social implications: is there a role for research ethics consultation? PLoS One (2009) 1.11

Barriers to Considering Ethical and Societal Implications of Research: Perceptions of Life Scientists. AJOB Prim Res (2012) 1.01

Scientific Citizenship and good governance: implications for biotechnology. Trends Biotechnol (2005) 0.98

Fundamental problems lie ahead in the drug discovery and commercialization process: restructuring of the pharmaceutical industry and an improved partnership with academia are required. J Investig Med (2006) 0.97

The "how" and "whys" of research: life scientists' views of accountability. J Med Ethics (2009) 0.93

Molecular geneticists and moral responsibility: "maybe if we were working on the atom bomb I would have a different argument. Sci Eng Ethics (1999) 0.90

Why we don't spend enough on public health. N Engl J Med (2010) 0.89

Genetic testing and its implications: human genetics researchers grapple with ethical issues. Sci Technol Human Values (2003) 0.89

Why science cannot be value-free: understanding the rationality and responsibility of science. Sci Eng Ethics (2009) 0.85

Scientific rationality, uncertainty and the governance of human genetics: an interview study with researchers at deCODE genetics. Eur J Hum Genet (2006) 0.84

Basic Blue Skies Research in the UK: Are we losing out? J Biomed Discov Collab (2008) 0.82

Societal and commercial issues affecting the future of biotechnology in the United States: a survey of researchers' perceptions. Naturwissenschaften (1998) 0.82

[The usefulness of useless knowledge]. Med Deporte Trab (1952) 0.78

Articles by these authors

Publications in PubMed on Ebola and the 2014 outbreak. F1000Res (2015) 1.01

Countries' Biomedical Publications and Attraction Scores. F1000Res (2014) 0.87